Journal of Modern OncologyJournal of Modern Oncology1815-14341815-1442LLC Obyedinennaya Redaktsiya26520Research ArticleArimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezySemiglazovV F-Zhil'tsovaE K-SemiglazovV V-IvanovV G-DashyanG A-Klettsel'A A-BozhokA A-NurgazievK S-TopuzovE E-Krivorot'koP V-TsyrlinaE V-BershteynL M-151220035415415609042020Copyright © 2003, Consilium Medicum2003[Моисеенко В.М., Семиглазов В.В., Тюляндин С.А. Современное лекарственное лечение местно - распространенного и метастатического рака молочной железы. Спб.: Грифон, 1997; 254 с.][Семиглазов В.Ф., Топузов Э.Э., Бавли Я.Л. Неоадъювантная химиотерапия в комплексном лечении рака молочной железы. Вопр. онкологии. 1992;4:27-32.][Buzdar A, Ваит M. Anastrozole in the treatment of breast cancer. London.UK.,2003; 110 p.][Nabholtzf Buzdar A, Pollak M. et al. Anastrazole is superior to tamoxifen as first - line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial, f C lin Oncol 2000; 18:3758-67.][Dixon F Anderson T, Miller W. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective. Eur J Cancer 2002; 38: 2214-21.][Eirmann W., Paepke S, Semiglazov V.F. Preoperative treatment of postmenopausal breast саncer patients with letrozole: a randomized double - blind multicenter study. Ann Oncol 2001; 12: 1527-32.][Miller W, Ingle F. Endocrine therapy in breast cancer. Marcel Dekker. New York, 2002; 378p.][Semiglazov V.F, Semiglazov W, Ivanov V.G. et al. Neoadjuvant endocrine therapy of postmenopausal breast cancer patients. Re International Congress ON anti - cancer treatment. Paris, 2003; Abs.p. 174.][Semiglazov V.F, Semiglazov W, Ivanov V.G. et al.Anastrazole (A) vs tamoxifen (T) vs (A+T) as neoadjuvant endocrine therapy of postmenopausal breast cancer patients. The Breast. 2003; 12: 87 (S39).]